LRP6 is expressed in human cancer cell lines and up-regulated in human malignant tissues [24], and LRP6 silencing weakens Wnt/β-catenin signaling and inhibits cell proliferation and tumor growth in breast and prostate cancers [25]. The gene discussed is LRP6; the disease is neoplasm.